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Nitric oxide/platelet activating factor cross-talk in mesangial During glomerular inflammation, mediators synthesized
cells modulates the interaction with leukocytes. by mesangial cells such as cytokines and chemokines, mod-
Background. Platelet activating factor (PAF) and nitric oxide ulate the expression of adhesion molecules involved in(NO) exert opposite effects on adherence and activation of
the control of infiltration, activation and differentiationcirculating leukocytes to endothelium. Several studies have im-
of leukocytes within the glomeruli. [2].plicated the production of PAF and NO by mesangial cells in
the regulation of glomerular filtration, permeability and inflam- Platelet activating factor (PAF) and nitric oxide (NO)
mation. However, the reciprocal interaction between PAF and have been implicated in the regulation of activation and
NO in mesangial cells and their role in leukocyte adhesion has
adherence of leukocytes to endothelium [3, 4]. In particu-not been investigated.
lar, the blockade of NO synthase (NOS) increases leuko-Methods. We evaluated whether blockade of constitutive
production of NO by two different NO synthase (NOS) inhibi- cyte adherence to endothelium that is inhibited by PAF-
tors (L-NAME and L-NMMA) could modulate PAF synthesis, receptor antagonists [5]. In glomerular pathophysiology,
and conversely whether exogenous PAF could influence the the production of PAF and NO by mesangial cells hasproduction of NO by mesangial cells. We evaluated whether
been studied for its possible implication in the regulationmodulation of PAF synthesis by NOS inhibitors could affect
of glomerular filtration, permeability and inflammationleukocyte adhesion to mesangial cells. The effect of PAF-recep-
tor antagonist WEB2170, of anti-2 integrins and intracellular [6, 7]. However, the relationship between PAF and NO
adhesion molecule-1 (ICAM-1) blocking antibodies and of sol- production in mesangial cells and their role in leukocyte
uble Sialyl-Lewis-a also was evaluated.
adhesion has not been investigated.Results. Blockade of NO synthesis by NOS inhibitors induced
PAF (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine)a spontaneous synthesis of PAF that was conversely inhibited
by NO generation. On the other hand, PAF inhibited both the belongs to a family of acetylated phosphoglycerides and
basal and l-arginine induced synthesis of NO by mesangial is produced from a large range of cells [8, 9]. PAF directly
cells. Moreover, NOS inhibition promoted the adhesion of induces mesangial cell contraction through a specificpolymorphonuclear cells and monocytes to mesangial cells by
G-coupled receptor [10] and mediates the effect of severala mechanism dependent on the synthesis of PAF and on the
polypeptide mediators such as tumor necrosis factor-interaction of 2 integrins and ICAM-1.
Conclusions. These data indicate that PAF and NO exhibit (TNF-) [11] and interleukin-12 (IL-12) [12]. In vivo,
a bi-directional effect on their respective synthesis in human PAF favors immune complex deposition in glomeruli,
mesangial cells, and suggest that their reciprocal regulation
and affects glomerular filtration and permeability in sev-may be relevant for leukocyte adhesion to glomerular mesan-
eral experimental models [13, 14]. Indeed, several studiesgial cells.
suggest that blockade of PAF receptor may improve
renal injury and vascular inflammatory lesions [15, 16].
NO within the mesangium of the kidney is synthesizedLeukocyte infiltration plays an important role in the
through constitutive and inducible forms of NOS isoen-initial kidney damage and consequent sclerosis that is
zymes [7], while NO synthesis and activation of solubleassociated with various forms of glomerular injury. [1]
guanylcyclase modulates relaxation/contraction of mes-
angial cells, thus regulating the glomerular filtration [17].Key words: platelet-activating factor, nitric oxide, mesangial cells, leu-
kocytes, glomerulonephritis, adhesion molecules, kidney sclerosis. In vivo, the role of NO in glomerulonephritis is contro-
versial. High NO production is commonly considered
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inactivation of endothelial NOS (eNOS) by disruption through a graded series of stainless steel meshes and iso-
lated uncapsulated glomeruli were recovered. Mesangialof the eNOS gene exacerbated renal injury and induced
a significant increase in glomerular leukocyte influx in cells (MC) were obtained from collagenase-treated iso-
lated glomeruli in order to remove the epithelial cella model of anti-glomerular basement membrane (anti-
GBM) glomerulonephritis [20]. Moreover, other studies component. Washed glomerular remnants were plated at a
density of about 300 glomeruli/cm2 in Dulbecco’s modifiedreported that NO blockade induced glomerular and tu-
bulointerstitial inflammation [21, 22]. Eagle’s medium (DMEM) and 20% fetal calf serum
(FCS). After three weeks in primary culture, mesangialThe aim of the present study was to investigate
whether NO could modulate PAF synthesis, and con- cells were harvested with 0.05% trypsin, 0.02% ethylene-
diaminetetracetate (EDTA). Subcultures were grown inversely whether PAF could influence the production of
NO by mesangial cells. We also evaluated whether block- the same medium. The cells used were characterized by
the following criteria [20]: (a) morphologic appearanceade of constitutive production of NO and modulation of
PAF synthesis by NOS inhibitors could affect leukocyte of stellate cells growing in interwoven bundles; (b) uni-
form fluorescence with F-PHD specific for F-actin; (c)adhesion to mesangial cells.
immunofluorescence staining for smooth muscle-type my-
osin; (d) immunofluorescence staining of extracellular
METHODS
matrix for type IV collagen and fibronectin using specific
Materials antisera; (e) negative immunofluorescence staining for
human lymphocyte antigen-DR (HLA-DR) and leuko-Polymyxin B, phospholipase A2, phospholipase A1,
BSA fraction V (tested for not more than 1 ng endotoxin cyte common antigen (CD-45) and human factor VIII
antigens. In parallel experiments, cell viability was moni-per mg), sphingomyelin and lyso-2-phosphatidylcholine
(lyso-PC), and FITC-conjugated goat anti-mouse IgG tored by Trypan blue and ranged between 88% and 95%.
were purchased from Sigma Chemical Company (St. Louis,
Preparation of human leukocytesMO, USA). Collagenase from C. Histolyticum was from
Boehringer (Mannheim, Germany); human factor VIII Human polymorphonuclear leukocytes (PMN) were
isolated from venous blood of healthy donors by sequen-antiserum was from Nordic Immunology (Tilburg, The
Netherlands); anti-smooth muscle cell myosin antibodies tial centrifugation and gelatin sedimentation [2.5% gela-
tin in phosphate-buffered saline (PBS), pH 7.2, for 30(Abs) were from Immunotech (Marseille, France); mouse
monoclonal anti-cytokeratin, anti-collagen type IV and min at 37C], as previously described [24]. Contaminat-
ing erythrocytes were removed by hypotonic lysis andanti-fibronectin Abs were from Labometrics (Milano,
Italy). Mouse monoclonal anti-human CD11a/LFA1, anti the cells resuspended in RPMI 1640 medium at the final
concentration of 3  106/mL. The percentage of PMNCD11b/Mac-1 and anti-human ICAM-1 Abs were from
Pharmingen (San Diego, CA, USA). Sialyl-Lewis-a tetra- in the cell preparation used in this study was 95 to 97%.
Monocytes were isolated from peripheral blood mono-saccharide was from Sigma. Synthetic PAF (1-hexadecyl-
2-acetyl-sn-glyceryl-3-phosphorylcholine) was obtained nuclear cells (PBMC) by adhesion to plastic dishes, as
described by Valone and Epstein [25]. Non-adherentfrom Bachem Feinchemikalien (Bubendorf, Switzer-
land); the stock solution in chloroform was stored at cells were removed by vigorous washing. Adherent cells
were90% monocytes as detected by non-specific ester-20C until use. The chloroform was evaporated and saline
containing 0.25% bovine serum albumin (BSA) fraction ase staining, and less than 1 platelet/10 monocytes was
detected. Cell viability, as determined by Trypan blueV, low endotoxin (Sigma) was added immediately before
use. WEB 2170 was obtained from Boehringer and CV exclusion, was 96 to 98%.
3988 from Takeda Chemical Industries (Kyoto, Japan).
Purification and quantification of PAFSodium nitroprusside (SNP), l-arginine, the NOS inhibi-
tors NG-monomethyl-l-arginine (L-NMMA) and NG-nitro- The production of PAF from mesangial cells after inhi-
bition of NO was studied. Cells were equilibrated forl-arginine-metyl ester (L-NAME), and their inactive en-
antiomers D-NMMA and D-NAME, 8-Bromo-cGMP, 15 minutes in Tris-buffered Tyrode containing 0.25%
delipidized BSA (fraction V), as previously describedsuperoxyde dismutase (SOD), and all cell culture re-
agents were from Sigma Chemical Co. Diaminofluor- [24] and incubated at 37C for the indicated time with
L-NAME or L-NMMA. To assess the specificity of theescein 2 diacetate (DAF-2 DA) was from Alexis Italia/
Biochem (Vinci, Italy). reaction, the NOS inhibitor enhantiomers were used.
Moreover, cells were stimulated with NO donors or with
Culture of human mesangial cells cGMP in the absence or presence of L-NAME. Selected
experiments were conducted in the presence of 5 g/mLHuman glomeruli were isolated from surgical specimen
of kidneys by the method described by Striker, Killen and Polymixin B for 30 minutes at 37C to exclude lipopolysac-
charide (LPS) contamination. The supernatants and theFarin [23]. The separated cortex was sliced and forced
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cell pellets were extracted according to a modification of trite production using the Greiss reaction, after nitrate
the Bligh and Dyer procedure [26], with formic acid was reduced into nitrite using NADPH [29]. Experi-
added to lower the pH of the aqueous phase to 3.0. Each ments were conducted in the presence of SOD to exclude
individual experiment was performed in duplicate. PAF nitrite production by oxygen radicals. Mesangial cell
was quantified after extraction and purification by thin were stimulated with vehicle or PAF or L-NAME and
layer chromatography (TLC; silica gel plates 60 F254; supernatants collected after 15 minutes. Cells were there-
Merck, Darmstardt, Germany) and high-pressure liquid fore stimulated for 15 minutes with l-arginine and super-
chromatography (HPLC; Porasil column; Millipore natants collected after another 15 minutes.
Chromatographic Division, Waters, MA, USA) by ag- The production of O2 was measured as the SOD inhib-
gregation of washed rabbit platelets, as previously re- itable reduction of ferricitochrome C, as previously de-
ported [24]. The biologically active material extracted scribed [30]. O2 production was expressed as nanomoles
from cells and supernatants in different experiments was of cytochrome C reduced/mg protein/time.
characterized by comparison with synthetic PAF ac-
PMN adherence assaycording to the following criteria [24]: (a) induction of
platelet aggregation by a pathway independent from Mesangial cells were grown to confluence in 96-well
both ADP and arachidonic acid/thromboxane A2-medi- plates, growth arrested for 24 hours and incubated with
ated pathways; (b) specificity of platelet aggregation as the NOS inhibitors L-NAME or L-NMMA or their inac-
inferred from the inhibitory effect of 5 mol/L WEB tive analogs D-NAME and D-NMMA for 30 minutes at
2170 or CV 3988, two different PAF receptor antagonists 37C. After stimulation, cells were washed twice. PMN
[27, 28]; (c) TLC and HPLC behavior and physicochemi- or monocytes suspension (2  105 cells in 100 L of
cal characteristics, such as inactivation by strong bases DMEM plus 10% FCS) was added to each well and
and by phospholipase A2 treatment, but resistance to leukocytes were allowed to adhere to mesangial cells for
phospholipase A1, acids, weak bases and five minutes 30 minutes at 37C under static conditions, as previously
of heating in boiling water. reported [31]. In selected experiments, the PAF receptor
antagonist WEB2170 (3 mol/L) was added to cells. ToEndogenous NO system studies
evaluate the role of 2 integrins in leukocyte adhesion,The cell-permeable NO reactive dye, DAF-2 DA was leukocytes were pre-incubated (10 min at room tempera-
used to examine intracellular production of NO in hu- ture) with 10 g/mL Abs against CD11a/LFA-1, CD11b/
man mesangial cells. Cells were washed three times with Mac-1 or IgG1 of irrelevant specificity (Sigma). After
PBS and then loaded with DAF-2 DA. Immediately
pre-incubation, leukocytes were added to mesangial cells.
before the use, DAF-2 DA stock solution (5 mmol/L)
To evaluate the role of selectins, mesangial cells werewas diluted to a final concentration of 5 mol/L in PBS-
incubated with soluble Sialyl-Lewis-a tetrasaccharide,BSA 0.25% (working solution). Mesangial cells were incu-
which binds to and inhibits adhesion dependent on E,bated 30 minutes at 37C within 1 mL/well of the working
L and P selectins. After the adherence period, PMN orsolution and then transferred to a Nikon Diaphot in-
monocytes were removed by gentle suction after threeverted microscope with 20 fluorescent objective in an
washes under rotary shaking (2 min at 80 rpm) withattached, hermetically sealed Plexiglas Nikon NP-2 incu-
equal volumes of cold medium. The number of adherentbator at 37C. Microscope was equipped with a Leika
PMN or monocytes was assessed by measuring their in-video camera connected to an IBM-compatible computer.
trinsic peroxidase activity. In brief, the mesangial cellExposure time was 1.76 seconds. Sequential exposures
monolayer and the adherent leukocytes were lysed withof the same microscopic field were acquired every 15
100 L 1% Triton-X100 (Sigma). The substrate reagentminutes. Image analysis was performed with MicroImage
solution (100 L, 3-ethylbenzthiazoline-6-sulfonic acid),analysis system (Cast Imaging srl, Venice, Italy). Experi-
1 mg/mL in citrate-phosphate buffer (pH. 4) was thenments were conducted in triplicate. To test the activity
added, and after five minutes of color development theof endogenous nitric oxide system, mesangial cells were
absorbance at 410 nm was determined. The number ofthen stimulated with l-arginine (1 mmol/L) or inhibited
adherent cells was subsequently calculated from a stan-with L-NAME (1 mmol/L) and then stimulated with
dard curve, obtained after 1% Triton-X100 lysis of deter-l-arginine. The role of PAF in the modulation of NO
mined number of PMN or monocytes (200,000 to 6250)production was studied by stimulation with PAF (10 to
from the same cell preparation used in the adherence50 nmol/L) in the absence or presence of l-arginine and
assay. Under the condition in the assay, there was awith WEB2170, the PAF receptor antagonist (3mol/L).
direct correlation between the number of leukocytes andIn each experiment, sodium nitroprusside (SNP; final
the optical density (r 0.998, N 12). In all experiments,concentration 10 to 100 mol/L; Sigma) was used as a
parallel wells containing either control or stimulatedNOS-independent NO donor to check the reactivity of
the system. Moreover, NO release was evaluated as ni- mesangial cells in the absence of leukocytes were used
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as controls. No peroxidase activity was observed in mes-
angial cells.
Determination of ICAM-1 expression
Intracellular adhesion molecule-1 expression was de-
termined by fluorescence-activated cell sorter (FACS)
analysis. Briefly, mesangial cells were detached from plates
with non-enzymatic cell dissociation solution (Sigma),
washed in PBS containing 2% heat-inactivated human
serum and incubated for another 15 minutes with whole
heat-inactivated human serum to block remaining non-
specific sites. Cells were then incubated for 30 minutes at
4C with the FITC-conjugated mouse monoclonal anti-
human ICAM-1 Ab or with the irrelevant FITC-conju-
gated mouse IgG1 (Dako, Carpinteria, CA, USA) in
PBS containing 2% heat-inactivated human serum. Cells
were analyzed on a FACS (Becton Dickinson, Mountain
View, CA, USA); 10,000 cells were analyzed in each
experimental point.
Statistical analysis
Statistical analyses were carried out using the GraphPad
Prism software. Statistically significant differences were
determined using analysis of variance (ANOVA) with
the Newman-Keul or Dunnet comparison tests.
RESULTS
NO blockade induced PAF production
Inhibition of endogenous NO production by L-NAME
(103 mol/L) induced a time-dependent synthesis of PAF
from mesangial cells (Fig. 1A). PAF produced after 30
Fig. 1. Platelet activating factor (PAF) production by mesangial cellsminutes of incubation with L-NAME (103 mol/L) was
after incubation with nitric oxide synthase (NOS) inhibitors. (A ) Time
associated to the cells. After 120 minutes, the synthesis course of PAF synthesis from 1  106 mesangial cells incubated with
106 mol/L L-NAME. L-NAME increased both cell-associated PAFof PAF was increased and PAF was detectable both as
() and PAF released in the supernatant (), as compared to cell-cell-associated and as released in the supernatant (Fig.
associated () or released (]) PAF from unstimulated cells. Data
1A). Cell viability tested at the end of each experiment represent the mean 	 SE of six individual experiments. (B ) PAF pro-
duction from 1106 mesangial cells (MC) incubated with two differentby Trypan blue dye exclusion test was 90%. Blockade
NOS inhibitors (103 mol/L, L-NAME or L-NMMA) or their rightof NOS with another NOS inhibitor, L-NMMA (103
inactive enantiomers (103 mol/L, D-NAME or D-NMMA) for 2 hours.
mol/L), also triggered PAF synthesis (Fig. 1B). To evalu- Data are the mean	 SE of three individual experiments; ANOVA with
Dunnet’s multicomparison test was performed among cell associated orate whether the synthesis of PAF induced by L-NAME
released PAF in the presence of vehicle versus PAF in the presence ofand L-NMMA was specifically related to NOS inhibition, NOS inhibitors (*P 
 0.05).
mesangial cells were challenged with their inactive right
enantiomers. No synthesis of PAF was observed when
cant increase in the synthesis and release of PAF wasmesangial cells were stimulated with D-NAME and
observed (Fig. 3).D-NMMA (103 mol/L; Fig. 1B). These results suggest that the basal NO production
To confirm the regulatory role of NO in PAF produc- by mesangial cells prevents the spontaneous synthesis of
tion, mesangial cells were incubated with L-NAME in PAF. Blockade of NOS not only triggers a spontaneous
the presence of exogenous NO or cGMP, the NO second- PAF synthesis, but it also enhances the inducible synthe-
ary mediator. Both the NO donor SNP (106 mol/L) and sis of PAF.
the cGMP analog (104 mol/L) dibutyryl cGMP abol-
PAF inhibited NO synthesisished PAF production induced by NO blockade (Fig. 2).
When IL-12, a cytokine known to induce PAF synthesis, Nitric oxide synthesis by mesangial cells was investi-
gated as production of fluorescence reactivity by DAF-2is combined with NOS inhibition by L-NAME, a signifi-
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Fig. 4. Photomicrographs representing the increase in NO-dependent
fluorescence by human mesangial cells. Details are in the Methods
Fig. 2. Platelet activating factor (PAF) production from 1 106 mesan- section. The appearance of fluorescent cells in the same field is moni-
gial cells incubated with vehicle alone, the nitric oxide (NO) donor tored by time-lapse fluorescent microscopy. As cells synthesize NO,
sodium nitroprusside (SNP; 106 mol/L) or the cyclic 3,5-guanosine they become detectable in the field. In basal conditions before stimula-
monophosphate (cGMP) donor, dibutyrril cGMP (cGMP, 104 mol/L) tion with l-arginine (103 mol/L) only few cells were detectable (A ).
in the absence or presence of 103 mol/L L-NAME. SNP and cGMP After addition of l-arginine, a progressive increase in the number of
completely inhibited the L-NAME induced PAF synthesis. Values are fluorescent cells was observed with a peak at 15 minutes (B ), followed
given as mean 	 SE of three individual experiments. ANOVA with by a slow decrease at 30 minutes (C ). Cells become negative after
Dunnet’s multicomparison test was performed among L-NAME versus 40 to 45 minutes (not shown). Lightening of individual cells was not
L-NAME plus SNP or cGMP (*P 
 0.05). synchronized and lasted for few minutes. No cells were detectable
before addition of l-arginine after 30 minutes of pre-incubation with
L-NAME (D ). After stimulation with l-arginine, only scattered and
minimal fluorescence was detectable at 15 minutes (E ), whereas NO
generation was delayed at 30 minutes (F ), as l-arginine competes with
L-NAME.
mol/L, 30 minutes at 37C; Figs. 4 and 5A). In mesangial
cells stimulated with the vehicle alone, the addition of
l-arginine (103 mol/L), the substrate for NOS, induced
a rapid increase in NO production, which was maximal
after 15 minutes and thereafter decreased (Fig. 4 A-C).
As expected [32], the treatment with L-NAME induced
a significant delay in the cell response to l-arginine, as it
was almost negative at 15 minutes and reached its maxi-
Fig. 3. PAF production from 1 106 mesangial cells incubated for two mum at 30 minutes of incubation (Fig. 4 D-F). In contrast,
hours at 37C with vehicle alone or with interleukin-12 (IL-12; 20
NO production was absent when cells were challengedng/mL) in the absence or presence of 103 mol/L L-NAME. L-NAME
increased PAF synthesis and its release into the supernatant. Values with 103 mol/L l-arginine after PAF stimulation (Figs.
are given as mean 	 SE of three individual experiments. Symbols 5A and 6 A-C). The endogenous NO levels also were
are: () cell associated; ( ) released. ANOVA with Newman-Keuls
lower than the basal after stimulation with PAF (108multicomparison test was performed among vehicle versus IL-12 and
versus IL-12 plus L-NAME (*P 
 0.05), and among IL-12 and IL-12 mol/L; Fig. 5A). Increase in fluorescence intensity due
plus L-NAME (§P 
 0.05). to exogenous NO (SNP 10 mol/L) was used as positive
control of the system (Figs. 5A and 6C). The study of
NO production by nitrite generation confirmed that
l-arginine was able to induce NO synthesis in basal con-DA in a system of time lapse cinematography. This sys-
ditions, but not after PAF stimulation (l-arginine aftertem allows the study of the modification in the NO-
incubation with vehicle alone, 5.1 	 1.7 mol/L NO/1 dependent fluorescence within a single cell after chal-
105 cells; l-arginine after incubation with 10 nmol/L PAF,lenge with several stimuli. Basal production of NO was
reduced when cells were incubated with L-NAME (103 0.6 	 0.5 mol/L NO/1105 cells; mean 	 1 SD of three
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Fig. 6. Micrographs representing the increase in NO-dependent fluo-
rescence by human mesangial cells by time-lapse fluorescent micros-
copy. After pre-incubation with 10 ng/mL PAF (30 min at 37C), no
cells were detectable in the microscopic field (A ). Cell remained nega-
tive after stimulation with l-arginine (103 mol/L) up to 30 minutes
(B ). Addition of the NO donor SNP (106 mol/L) increased the NO-
dependent fluorescence, indicating the efficacy of the system (C ). On
the contrary, few cells were detectable after per-incubation with PAF
plus WEB 2170, a PAF receptor antagonist (3  106 mol/L, 30 min
at 37C), which prevented the inhibitory effect of PAF (D ). After
Fig. 5. PAF inhibits NO production evaluated as fluorescence induced stimulation with l-Arginine, a progressive increase in the number of
by the cell-permeable NO reactive dye, DAF-2 DA. (A ) NO levels in fluorescent cells was observed at 15 minutes (E ), sustained up to 30
mesangial cells incubated with the vehicle alone (), 103 mol/L minutes (F ). Individual cells showed a great variability in the appear-
L-NAME ( ) or 10 ng/mL PAF. Cells were studied in basal conditions ance of NO-dependent lightening that varied from 15 to 30 minutes.
(30 min incubation at 37C), and then stimulated with the NOS substrate
l-arginine (103 mol/L). In all experiments, the reactivity of the system
was checked with exogenous addition of 106 mol/L SNP. Between 10
and 25 cells were analyzed for each experimental condition and repeated
nmol cytochrome C reduced/mg protein; PAF SODat least four times. ANOVA with Dunnet’s multicomparison test was
performed among basal versus l-arginine and SNP (*P
 0.05). (B ) No 38 	 22 nmol cytochrome C reduced/mg protein).
increase in NO-dependent fluorescence was observed in cells incubated These data suggest that the production of PAF inhibits
with PAF () or with PAF in the presence of SOD () after stimulation
the basal production of NO by a mechanism independentwith l-arginine, as compared to the unstimulated control (). Incuba-
tion of cells with PAF in the presence of WEB 2170 () induced a from oxygen radicals’ generation and dependent from
rapid increase in NO generation, which was not increased further by the engagement of PAF receptor.
l-arginine (l-ARG). Values are expressed as arbitrary units provided
by the computer image analysis and are given as mean 	 SD. ANOVA
NO blockade induced PAF-dependent PMN andwith Dunnet’s multicomparison test was performed for PAF versus
vehicle and versus PAF plus WEB or PAF plus SOD (*P 
 0.05). monocyte adhesion
Incubation of mesangial cells with two different NOS
inhibitors, L-NAME and L-NMMA (103 mol/L, 30 min
at 37C), increased the adhesion of PMN (Fig. 7A) andexperiments; P
 0.001). To evaluate whether PAF effect
monocytes (Fig. 7B). No increased adhesion was ob-was actually due to PAF receptor activation, mesangial
served after incubation with 103 mol/L D-NAME andcells were stimulated with PAF in the presence of the
D-NMMA, the inactive right enantiomers (Fig. 7). AsPAF receptor antagonist WEB 2170 (3 mol/L). The
mesangial cells synthesize PAF after challenge with NOSinhibitory effect of PAF on NO production was abro-
inhibitors, the effect of PAF in leukocyte adhesion wasgated by WEB 2170. In addition, blockade of PAF recep-
investigated using a PAF receptor antagonist WEB 2170tor by WEB2170 reverted the effect of l-arginine on
(3mol/L). WEB 2170 completely blocked the increasedNO production (Figs. 5B and 6 D-F). The inhibition of
adhesion of PMN and monocytes induced by NOS inhibi-reactive oxygen radicals by SOD (100 U/mL) did not
tors (Fig. 7A). Exogenous PAF, used as control, in-influence the inhibitory effect of PAF on NO synthesis
creased PMN adhesion to mesangial cells (Fig. 7A).(Figs. 5B and 6). In the same experimental condition,
Previous studies suggested that PAF mediates cellularSOD was shown to inhibit PAF-induced O2 production,
evaluated by cytochrome C reduction (PAF  260 	 45 adhesion through mechanisms involving selectins and 2
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Fig. 7. NOS inhibition induced PMN and monocyte adhesion by a
PAF-dependent mechanism. Adhesion of PMN (A ) or monocytes (B )
to mesangial cells preincubated with the NOS inhibitors L-NAME and
L-NMMA (103 mol/L), or with their inactive enantiomers D-NAME Fig. 8. L-NAME induced adhesion is dependent on 2 integrin-ICAM-1or D-NMMA. WEB 2170 (3 mol/L; ) added to PMN or monocytes interaction. Symbols are: ( ) vehicle; () L-NAME. Adhesion of PMN
prevented the effect of NOS inhibitors. Synthetic PAF (10 nmol/L) was (A ) or monocytes (B ) to mesangial cells preincubated with the NOS
used as positive control (). The adherent PMN or monocytes were inhibitors L-NAME (103 mol/L) was inhibited by the neutralizing
assessed by measuring their intrinsic peroxidase activity, as described anti-human ICAM-1, Mac-1 and LFA-3 antibodies (Abs), but not by
in the Methods section. The number of adherent cells per well was irrelevant IgG. On the contrary, Sialyl-Lewis-a, which binds to selectins,
calculated from a standard curve. Data are the mean 	 SE of three was unable to inhibit the adhesion induced by the NOS inhibitor. No
individual experiments performed in duplicate. ANOVA with Dunnet’s significant effect was induced by the Abs on the adhesion to unstimu-
multicomparison test was performed among vehicle versus treatment lated mesangial cells. The number of adherent cells per well was calcu-
with NOS inhibitors or PAF (*P 
 0.05) and among alone versus lated from a standard curve. Data are the mean	 SE of three individual
WEB2170 treatment (§P 
 0.05). experiments performed in triplicate. ANOVA with Dunnet’s multicom-
parison test was performed among L-NAME versus vehicle or versus
L-NAME plus Abs or Sialyl-Lewis (*P 
 0.05).
integrins. Therefore, we investigated the role of these
receptor for 2 integrins, as evaluated by FACS analysis.molecules in the adhesion induced by the L-NAME- L-NAME or PAF did not significantly increase the basal
dependent synthesis of PAF. Blockade of the 2 integrins expression of ICAM-1 after a two-hour incubation (Fig.
LFA-1 and Mac-1 reduced the effect of L-NAME on 9). The basal expression of ICAM-1 was sufficient to
PMN adhesion by 45% and 65%, respectively (Fig. 8). On support integrin-mediated interaction of leukocytes, as
the contrary, no inhibition of adherence was observed in the blockade of ICAM-1 inhibited both PMN and mono-
the presence of the soluble Sialyl-Lewis-a-tetrasaccha- cytes adhesion induced by L-NAME. These results sug-
ride, which binds to E, L and P selectins (Fig. 8A). Similar gest that the 2 integrins–ICAM-1 interaction is instru-
results were observed for monocytes (Fig. 8B). Mesangial mental in the adhesion of leukocytes to mesangial cells
after treatment with L-NAME.cells expressed in basal condition ICAM-1, the counter-
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in culture produced detectable levels of NO-dependent
fluorescence, as confirmed by the inhibitory effect of
L-NAME. Addition of PAF reduced the basal levels of
NO and impaired the arginine-dependent NO produc-
tion, indicating that PAF inhibits NO synthesis in mesan-
gial cells. Indeed, several mediators known to induce
PAF synthesis in mesangial cells, such as angiotensin II
and endothelin, also inhibit NO synthesis [33, 34]. Previ-
ous studies on endothelial cells suggested a balance be-
tween the action of PAF and NO. In fact, NO is known
to inhibit [4], whereas PAF promotes [35], leukocyte
adhesion to endothelium. In vivo, acute NO inhibition
promotes a rapid leukocyte infiltration into the microcir-
culation in various organs of the rat, cat and rabbit
[36, 37]. The present study provides direct evidence for
PAF synthesis after inhibition of basal NO production
in cultured human mesangial cells by two different NOS
inhibitors. Moreover, the production of PAF induced by
NOS inhibitors was blocked by the concomitant adminis-
tration of exogenous NO. These results are consistent
with the observation of an inhibitory effect of NO donors
on PAF synthesis in endothelial cells stimulated with
thrombin [38]. Blockade of NOS not only triggered a
spontaneous PAF synthesis, but it also enhanced the
inducible synthesis of PAF, as observed after stimulation
with IL-12. Indeed, the addition of L-NAME to IL-12
consistently potentiated the known effect of this cytokine
on PAF synthesis by mesangial cells [12]. This could
be relevant in inflammatory conditions, where multiple
inflammatory mediators may trigger PAF synthesis from
mesangial cells.Fig. 9. ICAM-1 expression by mesangial cells. (A ) Mesangial cells were
Concerning the inhibitory effect of PAF on NO syn-incubated with the anti-ICAM-1 Ab (thick line), or with an irrelevant
isotypic control IgG (thin line), as described in the Methods section. thesis, it may result from the interaction of NO with
(B ) No increase in ICAM-1 expression was observed after a 2-hour oxygen radicals that may be generated after PAF stimu-stimulation with L-NAME (103 mol/L, dotted line) or PAF (108
lation [8]. However, the incubation with SOD did notmol/L, dashed line) as compared to the basal (thick line). Two experi-
ments were carried out with similar results. modify the inhibitory effect of PAF on NO synthesis,
suggesting a modulation of NOS dependent on PAF-
receptor triggered cell signaling. Moreover, the observa-
tion that the inhibitory effect of PAF on NO generationDISCUSSION
was not modified by l–arginine, the substrate for NOS,Platelet activating factor and NO exert opposite effects
indicate that PAF acts to block this enzyme. Concerningon adherence and activation of circulating leukocytes.
the inhibitory effect of NO on PAF synthesis, we foundOur present study found that PAF and NO exhibit a bi-
that exogenously added cGMP, a NO intracellular sec-directional effect on their respective synthesis in human
ondary mediator, mimics the effect of NO and blocksmesangial cells. Blockade of NO synthesis by two differ-
L-NAME-induced PAF synthesis. This suggests that aent NOS inhibitors induced a spontaneous synthesis of
cGMP dependent pathway is involved in the modulationPAF, which was conversely inhibited by NO generation.
of PAF biosynthesis in mesangial cells. Altogether, theseOn the other hand, PAF inhibited both the basal and
data indicate the presence of an intracellular cross-talkl-arginine induced synthesis of NO by mesangial cells.
between PAF and NO due to their secondary mediators.Moreover, we found that NO inhibition promoted the
It has been previously demonstrated that the cGMP-adhesion of PMN and monocytes to mesangial cells by
dependent protein kinase may prevent the biosynthesisa mechanism dependent on the synthesis of PAF.
of PAF as results of the inhibition of PLA2 activity, whichSeveral studies indicate that NO synthesized by mes-
is required for the agonistic-stimulated synthesis of PAFangial cells plays a relevant role in kidney physiology
and pathophysiology [7]. We found that mesangial cells [39]. Moreover, a similar mechanism of molecular cross-
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